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Adequacy of an early arterial phase low-volume
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and Barry T. Katzen, MD,a Miami, Fla; Bern, Switzerland
Purpose: This retrospective study was conducted to determine whether a low-volume contrast medium protocol provides
sufficient enhancement for 64-detector computed tomography angiography (CTA) in patients with aortoiliac aneurysms.
Methods: Evaluated were 45 consecutive patients (6 women; mean age, 72  6 years) who were referred for aortoiliac
computed tomography angiography between October 2005 and January 2007. Group A (22 patients; creatinine
clearance, 64.2 8.1 mL/min) received 50 mL of the contrast agent. Group B (23 patients; creatinine clearance, 89.4
7.3 mL/min) received 100 mL of the contrast agent. The injection rate was 3.5 mL/s, followed by 30 mL of saline at 3.5
mL/s. Studies were performed on the same 64-detector computed tomography scanner using a real-time bolus-tracking
technique. Quantitative analysis was performed by determination of mean vascular attenuation at 10 regions of interest
from the suprarenal aorta to the common femoral artery by one reader blinded to type and amount of contrast agent and
compared using the Student t test. Image quality according to a 4-point scale was assessed in consensus by two readers
blinded to type and amount of contrast medium and compared using the Mann-Whitney test. Multivariable adjustments
were performed using ordinal regression analysis.
Results:Mean total attenuation did not differ significantly between both groups (196.5 33.0 Hounsfield unit [HU] in
group A and 203.1  44.2 HU in group B; P  .57 by univariate and P > .05 by multivariable analysis). Accordingly,
attenuation at each region of interest was not significantly different (P > .35). Image quality was excellent or good in all
patients. No significant differences in visual assessment were found comparing both contrast medium protocols (P> .05
by univariate and by multivariable analysis).
Conclusions: Aortoiliac aneurysm imaging can be performed with substantially reduced amounts of contrast medium
using 64-detector computed tomography angiography technology. (J Vasc Surg 2008;47:492-8.)With the development of multidetector technology,
computed tomography angiography (CTA) has evolved as
one of the modalities of choice for aortoiliac imaging,
particularly in the evaluation of aneurysmal disease.1-3 In
contrast with open surgical abdominal aortic aneurysm
(AAA) repair, endovascular AAA repair (EVAR) requires
precise preprocedural and follow-up imaging.4 Sufficient
arterial enhancement is essential to precisely assess vascular
anatomy in the surveillance of AAA, for planning before
EVAR, and during follow-up. Improved arterial enhance-
ment can be achieved by increases in the intravenous con-
trast medium (CM) iodine concentration, total CM vol-
ume administered, or rate of CM infusion.5 Thus, the use
of high-concentration, high-volume, and rapid injection
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492rate CM has been accepted in several CT applications to
improve enhancement.5-9
Contrast nephropathy is a well-recognized complica-
tion of CM use.10-12 Among several other mainly nonin-
fluenceable risk factors such as baseline renal function,
diabetes mellitus, and patient age, the volume of CM given
along with its concentration directly correlates with the risk
of contrast nephropathy.10,13-15 Chronic kidney disease is
encountered in 7% to 25% of patients undergoing EVAR
and, owing to the need for preprocedural and follow-up
contrast-enhanced CTA imaging, is a potential limitation
to the use of this minimally invasive treatment option.16,17
With the recent introduction of 64-detector CT scan-
ners, scan volumes can be imaged much faster, thus allow-
ing protocols to thinly image the aortoiliac segment within
a few seconds. As a result, scan optimization with the
contrast bolus becomes more challenging. The shorter
scanning time of the 64-detector CT scanner may enable a
more efficient use of CM; therefore, the amount of CM
injected may be reduced without decreasing contrast
enhancement. The purpose of this study was to retrospec-
tively determine whether a low-volume CM protocol pro-
vides sufficient enhancement and imaging quality for 64-
detector CTA in patients with aortoiliac aneurysms.
MATERIALS AND METHODS
Patients. We studied 45 patients (6 women), with a
mean age 72 6 years, who had undergone aortoiliac CTA
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retrospective data review for this study was obtained. Be-
tween October 2005 and January 2007, 22 patients (group
A) underwent CTA with a reduced CM volume of 50 mL.
These were compared with 23 consecutive patients (group
B) who had undergone CTA with our standard protocol of
100mL of CMon the same 64-detector scanner during the
same period of time. Patients had been examined clinically
between 1 and 2 weeks after CTA had been performed but
had not undergone routine laboratory screening for renal
function. Patient baseline characteristics are outlined in
Table I. After EVAR, 22 patients were analyzed, consisting
of 10 patients in group A and 12 in group B.
Indication for use of the reduced CM protocol had
been determined clinically by the referring interventionalist
or monitoring radiologist in patients with impaired renal
function according to earlier experiences with a reduced
amount of contrast in patients undergoing CTA using
8-detector technology.18 Except for a decreased creatinine
clearance in group A, patient baseline characteristics did
not differ significantly between the groups.
Scanning protocol. All CT scans were performed
with a 64-detector CT scanner (Brilliance 64; Philips Med-
ical Systems; Best, Netherlands). The CM was injected
through an 18-gauge cannula in an antecubital vein using a
power injector (Envision, Medrad, Pittsburgh, Pa). The
following CM types were used: Optiray 320 (Ioversol,
Mallinckrodt, Hazelwood, Mo; iodine, 320 mg/mL; vis-
cosity at 37°C, 5.8 cps) in 24 patients, Visipaque 320
(Iodixanol, Amersham Health, Princeton, NJ; iodine, 320
mg/mL; viscosity at 37° C, 11.8 cps) in three, and Optiray
350 (Ioversol; iodine, 350 mg/mL; viscosity at 37° C, 9.0
cps) in 18. The CM injection rate was 3.5 mL/s and was
followed with 30 mL of saline injected at 3.5 mL/s in all
patients (Table II).
The start of the scanning was triggered automatically
by a real-time bolus tracking technique. A region of interest
(ROI) in the proximal abdominal aorta was used to moni-
tor the bolus. The scanning started 6 seconds after the
enhancement of the ROI had crossed the 200 Hounsfield
unit (HU) threshold trigger. Further data acquisition set-
Table I. Patient baseline characteristics
Characteristic Group
Age, mean  SD years 7
Female sex, No. (%)
AAA diameter, mean  SD mm 49.
Body weight, mean  SD lb 16
Creatinine clearance, mean  SD mL/min 64.
Pre-EVAR, No. (%) 1
Post-EVAR, No. (%) 1
EVAR, Endovascular aortic aneurysm repair.
aReceived 50 mL of contrast medium.
bReceived 100 mL of contrast medium.
cP from t test.
dP from Fisher exact test.tings were 0.625 mm  64 detectors, 140 KvP, 400 mA,reconstructed at 2-mm thickness every 1 mm. The 100-mL
protocol (group B, Fig 1) used a 1-second rotation time,
pitch of 0.89, for an average 14-second scan time. The
50-mL CM protocol (group A, Fig 2) used a 0.75-second
rotation time, pitch of 0.89, decreasing the average scan
time to 10 seconds. Delayed images were performed in
post-EVAR patients using the same imaging settings 30
seconds after completion of the arterial phase images.
Quantitative analysis. Contrast-enhanced CTA im-
ages during the arterial phase were displayed on a picture
archiving and communication system (PACS) workstation
(Philips Medical Systems, Best, the Netherlands) in a ran-
domized order and interpreted by an endovascular inter-
ventionist (N. D.) with a special interest in aortic CT and 7
years of experience in vascular imaging who was blinded to
type and amount of CM.
Themagnitude and uniformity of arterial enhancement
was measured using circular ROIs in the arterial center
along the abdominal aortic z-axis at seven different
ROIs.18-20 An attempt was made to select a ROI area
containing as much of the intravascular segment as possible
but not so large that it approached the partly calcified edges
of the vessel. The suprarenal aorta (ROI 1) was defined as
the first CT slice above the highest renal artery. The left
renal artery (ROI 2a) and right renal artery (ROI 2b) were
defined as the axial CT slice with best depiction of the renal
artery. The infrarenal aortic neck (ROI 3) was defined as
 22)a Group B (n  23)b P
72  6 .54c
) 3 (13%) .99d
1.5 53.6  12.6 .29c
7 177  22 .26c
.1 89.4  7.3 .02c
) 11 (48) .99d
) 12 (52)
Table II. Injection protocol
Groups
Contrast medium
Amount Type No.
Group A 50 mL Optiray 320 11
Optiray 350 8
Visipaque 320 3
Total 22
Group B 100 mL Optiray 320 13
Optiray 350 10
Visipaque 320 0
Total 23A (n
2  6
3 (14
8  1
5  2
2  8
2 (55
0 (45the first CT slice below the lowermost renal artery. The
aort
ent
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contrast-enhanced aortic flow channel at the level of max-
imal AAA dilatation. In post-EVAR patients, attenuation
values were measured within the graft. In case the maxi-
mally dilated sac was located at the level of both graft limbs,
attenuation values were measured in both graft limbs and
values were averaged.
The aortic bifurcation level (ROI 5) was defined as the
first CT slice above the aortic bifurcation. In post-EVAR
patients, attenuation values were measured in both graft
limbs and values were averaged. The distal common iliac
artery (ROI 6a, left; ROI 6b, right) was defined as the
common iliac artery on the first slice above the iliac bifur-
cation. The proximal common femoral artery (ROI 7a, left;
ROI 7b, right) was defined as the common femoral artery
Fig 1. Representative 64-detector computed tomograp
man with a 55-mm abdominal aortic aneurysm. A, Trans
transverse diameter. Arterial attenuation, 201.5HU.B, S
iliac artery with adequate arterial enhancement along the
Fig 2. Representative 64-detector computed tomograp
woman with a 48-mm abdominal aortic aneurysm. A, T
widest transverse diameter. Arterial attenuation, 195.7 H
and common iliac artery with adequate arterial enhancemon the first slice above the femoral bifurcation.Visual assessment. The axial, sagittal, and reformat-
ted coronal and volume-rendered images were displayed on
a PACS workstation and evaluated in a randomized order
on a consensus basis by a diagnostic and interventional
radiologist with 8 years experience in aortic imaging (C. P.)
and an endovascular interventionist with a special interest
in aortic CT and 7 years of experience in vascular imaging
(N. D.) who were blinded to the volume of CM used.
Images were analyzed at the previously specified ab-
dominal aortic ROIs. The following 4-point scale21-23 was
used for assessment of overall image quality and visual
depiction of arterial landmarks defined as ROIs 1 to 7 as
well as for analysis of the quality of intraprosthesis vs
extraprosthesis enhancement: 1  excellent; 2  good; 3 
sufficient; and 4  poor. Accordingly, the quality of intra-
age with 100 mL of contrast medium in a 72-year-old
image shows the infrarenal aortic aneurysm at its widest
l reconstruction shows the infrarenal aorta and common
oiliac segment.
age using 50 mL of contrast medium in an 82-year-old
verse image shows the infrarenal aortic aneurysm at its
, A reconstructed sagittal view shows the infrarenal aorta
along the aortoiliac segment.hy im
verse
agittahy im
rans
U. Bprosthesis vs extraprosthesis enhancement was assessed on
for b
nuatio
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presence of endoleaks in post-EVAR patients on delayed
CTA images. If the readers disagreed on the quality of the
image, the worse category was assumed. Special care was
taken to assess the presence of endoleaks in post-EVAR
patients on delayed CTA images.
Statistical analysis. Continuous variables are presen-
ted as mean  standard deviation (SD). Categoric data are
given as counts and percentages. All statistical analyses were
performed using SPSS 12.0.1 statistical software (SPSS Inc,
Chicago, Ill). The Student t test was used to compare
aortoiliac attenuation between the two patient groups after
positive assessment for normal distribution of continuous
data. To compare the uniformity of the contrast column,
we calculated the difference between the maximum and
minimum attenuation values along the z-axis for each pa-
tient. The Mann-Whitney test was used to verify visual
estimation results. Multivariable linear regression analysis
was performed to assess the association between viscosity,
Fig 3. Mean attenuation  SD along the aortoiliac z-
(circle, solid line), and for group B, which received 100 m
constant arterial enhancement along the aortoiliac z-axis
Table III. Comparison of mean attenuation between pati
mL vs 100 mL contrast medium
Regions of interest
Group A (50 mL CM)
Mean SD Ra
1 211.7 46.1 129-
2a 187.0 43.2 109-
2b 188.0 46.5 125-
3 215.9 45.9 132-
4 217.9 50.8 129-
5 213.9 44.1 131-
6a 202.1 50.2 119-
6b 199.0 45.3 129-
7a 198.2 51.1 122-
7b 201.6 51.0 117-
1 to 7 203.1 44.2 127-
HUmax – HUmin
b 62.4 29.03 16-
CM, Contrast medium.
aP values from t test.
bMean difference between maximum and minimum (Hounsfield units) atteiodine concentration, and amount of CM with results fromvisual assessment and quantitative analysis. A value of P 
.05 was considered statistically significant.
RESULTS
Computed tomography imaging was accomplished
without adverse events in all patients. Endoleaks were
diagnosed on 2 of 12 (17%) delayed post-EVARCTA scans
in the 100-mL CM group in patients exhibiting AAA sac
expansion, whereas no post-EVAR CTA scan from the
50-mL CM group showed AAA sac expansion or enhance-
ment outside the aortic endograft. In the first patient, a
type Ia endoleak was confirmed on a further CT scan 1
month later using 100-mL of CM, and in the second
patient, a type II endoleak had been diagnosed 6 months
before the CT was analyzed and was further confirmed
during an AAA sac injection and embolization procedure.
Aortoiliac enhancement. No significant differences
in attenuation were noted comparing the single ROIs
between the groups (P  .35, Table III, Fig 3). The mean
r group A, which received 50 mL of contrast material
contrast material (square, dotted line). The graph shows
oth protocols (P  .05). ROI, Region of interest.
undergoing computed tomography angiography using 50
Group B (100 mL CM)
PaMean SD Range
202.5 34.5 137-263 .49
174.3 48.3 94-313 .45
177.1 43.33 95-287 .52
203.9 33.1 140-261 .35
202.4 36.2 141-272 .26
204.4 43.9 134-296 .51
188.5 32.6 137-253 .34
193.1 35.5 135-262 .71
208.1 39.5 150-294 .43
208.7 39.3 132-300 .55
196.5 33.0 139-277 .57
69.6 25.2 29-122 .38
n values along aortoiliac z-axis.axis fo
L ofents
nge
278
259
302
285
328
283
300
275
277
275
276
143total attenuation of the aortoiliac segment was 203.1 
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(P  .57, Table III). The mean difference between the
maximum and minimum attenuation values along the z-
axis did not differ significantly between group A and group
B, indicating the presence of a uniform contrast column for
CTA performed with both CM protocols (P  .38, Table
III). Multivariable linear regression analysis adjusted for
viscosity, iodine concentration, and amount of CM con-
firmed that none of these factors independently influenced
aortoiliac attenuation of all ROIs analyzed (P  .05).
Visual assessment. Contrast-enhanced aortoiliac CTA
was graded as excellent or good in all patients (Table IV).
No significant differences in visual CTA assessment were
found when the two CM protocols (P  .05) were com-
pared. Multivariable linear regression analysis adjusted for
viscosity, iodine concentration, and amount of CM con-
firmed that none of these factors independently influenced
visual assessment results (P  .05).
DISCUSSION
Contrast medium–enhanced examinations are the
third leading cause of hospital-acquired acute renal fail-
ure,24 and renal insufficiency is a significant limitation to
the use of EVAR in medically frail AAA patients. Our study
indicates that 64-detector CTA imaging in patients with
aortoiliac aneurysms can be performed with substantially
reduced CM volumes without sacrificing arterial attenua-
tion and imaging quality. Thus, given the direct relation-
ship of CM volume with the risk of contrast nephropa-
thy,10,13-15 findings from the present study may help to
lower the risk of contrast nephropathy for AAA patients
undergoing CTA and expand the applicability of CTA to
patients with borderline renal function.
Adequate and uniform enhancement is essential in
aortoiliac CTA imaging before and after EVAR. The most
important factor affecting the magnitude of contrast en-
Table IV. Visual assessment results
Group A, n  22
(50 mL CM)
Group B, n  23
(100 mL CM)
Gradea 1 2 3 4 1 2 3 4
Overall image quality 17 5 0 0 15 8 0 0
Depiction of ROI 1 18 4 0 0 17 6 0 0
Depiction of ROI 2a 18 4 0 0 17 6 0 0
Depiction of ROI 2b 18 4 0 0 17 6 0 0
Depiction of ROI 3 17 5 0 0 17 6 0 0
Depiction of ROI 4 16 6 0 0 17 6 0 0
Graft vs sac enhancement 9 3 0 0 7 4 0 0
Depiction of ROI 5 14 8 0 0 14 9 0 0
Depiction of ROI 6a 14 8 0 0 14 9 0 0
Depiction of ROI 6b 14 8 0 0 14 9 0 0
Depiction of ROI 7a 14 8 0 0 14 9 0 0
Depiction of ROI 7b 14 8 0 0 14 9 0 0
Total 15.3 5.9 0 0 14.8 7.3 0 0
CM, contrast material; ROI, region of interest.
aA 4-point scale was used for qualitative assessment: 1, excellent; 2, good;
3, sufficient; and 4, poor.hancement achieved is the iodine flux; that is, the amountof iodine entering the circulation per unit of time, which in
turn is influenced by the rate and volume of injection and
the iodine concentration of the CM.5 By diminishing the
volume of CM, a significant impact of total iodine admin-
istered can be effected.13,14 A reduction of CM dose was
shown to yield acceptable attenuation and imaging quality
in aortoiliac CTA using a 16-detector scanner.25 In that
series, however, the CM dose was only reduced by 20%,
resulting in the use of CMdoses of 100mL.25 Accordingly,
it has recently been shown that the amount of CM can be
reduced when 64-detector technology is used in various
other applications such as depiction of pulmonary26 and
coronary27 arteries.
The present series, to our knowledge, is the first to
investigate the effect of a reduced amount of CM on
attenuation and depiction of aortoiliac anatomy using 64-
detector technology. In our study, arterial attenuation val-
ues when the low-volume CM protocol (50 mL) was used
were not quantitatively different from values obtained in pa-
tients undergoing CTA with the standard, higher-volume
CM protocol. The advent of 64-detector CTA increased
scanning speed and was associated with increased spatial
resolution.9,28 Nevertheless, the degree of contrast en-
hancement achieved is directly proportional to the volume,
rate, and concentration of iodine used.29,30 Increased scan-
ning speed necessitates an accurate synchronization of CT
image acquisition with CM delivery and enables a more
efficient use of CM. Thus, by using a shorter rotation time
in patients receiving a reduced amount of CM in the
present study, the contrast bolus could be followed faster,
thereby decreasing CM volumes needed without affecting
arterial attenuation. Furthermore, qualitative measure-
ments in our study showed that image quality was excellent
or good in both protocol groups. Hence, observations
from the present series underline that the amount of CM
can be further reduced without sacrificing image quality
using 64-detector CTA.
The use of a saline flush after CM injection with a
dual-head power injector can aid to decrease the total
amount of CM required for optimal tissue enhancement by
eliminating the dead space between the brachial vein and
the superior vena cava. When flushing with saline solution,
pooling of CM in the injection system and the arm veins is
avoided. Several studies have shown the potential of a saline
solution flush in CM dose reduction in multi-slice CTA in
various arterial segments.19,31,32
There are limitations to our study. First, this was a
retrospective and nonrandomized study. For this reason,
not all patient baseline factors that affect cardiac output
could be systematically assessed. Important patient charac-
teristics such as body weight and AAA size were similar,
however, and the different types of CM used were distrib-
uted equally in both groups. We also performed multivari-
able linear regression analysis adjusted for potentially con-
founding factors.
Second, the mean AAA diameter in patients from the
present series was not excessively large. Our study therefore
does not allow for a dedicated subgroup analysis of imaging
JOURNAL OF VASCULAR SURGERY
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tration of a lower CM dose might potentially lead to a
decrease in attenuation and imaging quality due to slower
flow situations.
Third, the present series contained only two patients
with endoleaks in the group that underwent CTA with the
standard volume of CM and did not allow for a comparison
with a reference standard imaging method. However, all
patients from the reduced CM group exhibited AAA
shrinkage, and visual assessment revealed a good to excel-
lent differentiation of intragraft vs AAA sac enhancement in
all delayed CTA images of post-EVAR patients, indicating
a high probability of endoleak detection with either proto-
col. Thus, it cannot be entirely ruled out that the absence of
endoleak visualization could be due to an absence of en-
doleak, to inadequate timing, or to reduced volume of
contrast administered.
Fourth, this retrospective series contained three types
of CM that differed slightly with regard to viscosity and
concentration. As shown within a multivariable regression
analysis, these potentially confounding factors did not in-
fluence visual analysis or arterial attenuation. Of interest is
that others have previously made similar observations with
regard to attenuation and the specific iodine concentrations
used in the present series.33
Finally, our study, unfortunately, was not designed to
elucidate the effect of lower contrast volume studies on
renal function after imaging.
CONCLUSIONS
A 64-detector CTA protocol that uses half the amount
of CM compared with the standard protocol provides
uniform attenuation and excellent visual depiction of the
anatomic details in aortoiliac imaging. Given the direct
relationship of CM exposure and contrast nephropa-
thy,13,14 and considering the need for repeated CTA im-
aging in AAA patients,34 a reduction in the volume of CM
may offer improved imaging options in AAA patients with
borderline renal function and renal insufficiency. More-
over, a reduction of CM volumes has the potential to
decrease costs of routine CTA. Further research is war-
ranted to prospectively assess the ability of the present
low-volume CM protocol in depiction of endoleaks and
prevention of contrast nephropathy.
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